下痢:パイプラインレビュー2019下半期

調査会社Global Markets Direct社が発行したリサーチレポート(データ管理コード:GDATA9120315)
◆英語タイトル:Diarrhea - Pipeline Review, H2 2019
◆発行会社/調査会社:Global Markets Direct
◆商品コード:GDATA9120315
◆発行日:2019年11月
◆調査対象地域:グローバル
◆産業分野:製薬及び医療
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,000 ⇒換算¥228,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD6,000 ⇒換算¥684,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Global Markets Direct社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[下痢:パイプラインレビュー2019下半期]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Diarrhea – Pipeline Review, H2 2019
Summary

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea – Pipeline Review, H2 2019, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape.

Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Diarrhea – Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Diarrhea (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 10, 5, 15, 5 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 1, 3 and 5 molecules, respectively.

Diarrhea (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Diarrhea (Gastrointestinal).
- The pipeline guide reviews pipeline therapeutics for Diarrhea (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Diarrhea (Gastrointestinal) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Diarrhea (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Diarrhea (Gastrointestinal)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Diarrhea (Gastrointestinal).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Diarrhea (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

*** レポート目次(コンテンツ)***

Table of Contents
Introduction
Diarrhea – Overview
Diarrhea – Therapeutics Development
Diarrhea – Therapeutics Assessment
Diarrhea – Companies Involved in Therapeutics Development
Diarrhea – Drug Profiles
Diarrhea – Dormant Projects
Diarrhea – Discontinued Products
Diarrhea – Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Diarrhea, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Products under Development by Companies, H2 2019 (Contd..2), H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Diarrhea - Pipeline by Akthelia Pharmaceuticals Ltd, H2 2019
Diarrhea - Pipeline by Albireo Pharma Inc, H2 2019
Diarrhea - Pipeline by Allergan Plc, H2 2019
Diarrhea - Pipeline by AzurRx BioPharma Inc, H2 2019
Diarrhea - Pipeline by Boston Pharmaceuticals Inc, H2 2019
Diarrhea - Pipeline by Chongqing Zhifei Biological Products Co Ltd, H2 2019
Diarrhea - Pipeline by Cosmo Pharmaceuticals NV, H2 2019
Diarrhea - Pipeline by DiscoveryBiomed Inc, H2 2019
Diarrhea - Pipeline by Ferring International Center SA, H2 2019
Diarrhea - Pipeline by Immuron Ltd, H2 2019
Diarrhea - Pipeline by Kaleido Biosciences Inc, H2 2019
Diarrhea - Pipeline by Kuhnil Pharmaceutical Co Ltd, H2 2019
Diarrhea - Pipeline by MyBiotics Pharma Ltd, H2 2019
Diarrhea - Pipeline by Napo Pharmaceuticals Inc, H2 2019
Diarrhea - Pipeline by Nippon Shinyaku Co Ltd, H2 2019
Diarrhea - Pipeline by Novartis AG, H2 2019
Diarrhea - Pipeline by Pharmascience Inc, H2 2019
Diarrhea - Pipeline by Prokarium Ltd, H2 2019
Diarrhea - Pipeline by Protagonist Therapeutics Inc, H2 2019
Diarrhea - Pipeline by RaQualia Pharma Inc, H2 2019
Diarrhea - Pipeline by RedHill Biopharma Ltd, H2 2019
Diarrhea - Pipeline by RxBio Inc, H2 2019
Diarrhea - Pipeline by Scandinavian Biopharma Holding AB, H2 2019
Diarrhea - Pipeline by Synthetic Biologics Inc, H2 2019
Diarrhea - Pipeline by Syntiron LLC, H2 2019
Diarrhea - Pipeline by VenatoRx Pharmaceuticals Inc, H2 2019
Diarrhea - Dormant Projects, H2 2019
Diarrhea - Dormant Projects, H2 2019 (Contd..1), H2 2019
Diarrhea - Dormant Projects, H2 2019 (Contd..2), H2 2019
Diarrhea - Discontinued Products, H2 2019

List of Figures
Number of Products under Development for Diarrhea, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019

*** 掲載企業 ***

Akthelia Pharmaceuticals Ltd
Albireo Pharma Inc
Allergan Plc
AzurRx BioPharma Inc
Boston Pharmaceuticals Inc
Chongqing Zhifei Biological Products Co Ltd
Cosmo Pharmaceuticals NV
DiscoveryBiomed Inc
Ferring International Center SA
Immuron Ltd
Kaleido Biosciences Inc
Kuhnil Pharmaceutical Co Ltd
MyBiotics Pharma Ltd
Napo Pharmaceuticals Inc
Nippon Shinyaku Co Ltd
Novartis AG
Pharmascience Inc
Prokarium Ltd
Protagonist Therapeutics Inc
RaQualia Pharma Inc
RedHill Biopharma Ltd
RxBio Inc
Scandinavian Biopharma Holding AB
Synthetic Biologics Inc
Syntiron LLC
VenatoRx Pharmaceuticals Inc

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 往復のこぎりの世界及び中国市場 2018年
    The 'Global and Chinese Reciprocating Saws Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Reciprocating Saws industry with a focus on the Chinese market. The report provides key statistics on the market status of the Reciprocating …
  • スープの中国市場
    Soups in China Summary Soups in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of compet …
  • ブリブジンの世界市場2021
    Brivudine (CAS 69304-47-8) Market Research Report 2021 aims at providing comprehensive data on Brivudine market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Brivudine description, covers its application areas, manufacturing methods, patents. It captur …
  • アフェクティブコンピューティングの世界市場 2019年-2023年
    In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Affective Computing Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regi …
  • 脳卒中の診断および治療の世界市場2017-2026
    According to Stratistics MRC, the Global Stroke Diagnostics and Therapeutics market is accounted for $23,849.39 Million in 2017 and is expected to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period. Factors such as technological advancement, growing aging populatio …
  • 女性医療の世界市場
    In this report, the global Women's Health market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (m …
  • タバコ用包装の世界市場
    In this report, the global Cigarette Packaging market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, reven …
  • 金属研磨機の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Metallographic Polishing Machine Revenue, means the sales value of Metallographic Polishing Machine This report studies sales (consumption) of Metallographic Polishing Machine in Global market, especially in United States, China, Europe and Japan, focuses on to …
  • 家具用皮革の世界市場インサイト及び予測 2027年
    Market Analysis and Insights: Global Leather Used in Furniture Market The global Leather Used in Furniture market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Leather Used in Furniture Scope and S …
  • フローリングの世界市場2016-2022
    According to Stratistics MRC, the Global Flooring market accounted for $258 billion in 2015 and it is projected to reach $367.82 Billion by 2022, growing at a CAGR of 5.2% from 2015 to 2022. Mounting demand for insulation, surging demand in the construction industry and varying customer lifestyles a …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDATA9120315 )"下痢:パイプラインレビュー2019下半期" (英文:Diarrhea - Pipeline Review, H2 2019)はGlobal Markets Direct社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。